2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide

C22H21ClF2N6O2 — CID 159464097

IUPAC2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide
SMILESCC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)c(F)c1F
InChIInChI=1S/C22H21ClF2N6O2/c1-11(2)27-18(32)10-33-16-7-5-13(20(24)21(16)25)22-28-17(31(3)30-22)8-12-4-6-15-14(19(12)23)9-26-29-15/h4-7,9,11H,8,10H2,1-3H3,(H,26,29)(H,27,32)
InChIKeyLUYPQQJZYZMXPG-UHFFFAOYSA-N
MW474.90 g/mol
LogP3.78
Rot. Bonds7

About 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide

2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide (PubChem CID 159464097) has the molecular formula C22H21ClF2N6O2 and a molecular weight of 474.90 g/mol. Its IUPAC name is 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide.

Molecular Properties

Compound Name2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide
PubChem CID159464097
Molecular FormulaC22H21ClF2N6O2
Molecular Weight474.90 g/mol
Exact Mass474.14
IUPAC Name2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide
SMILESCC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)c(F)c1F
InChIInChI=1S/C22H21ClF2N6O2/c1-11(2)27-18(32)10-33-16-7-5-13(20(24)21(16)25)22-28-17(31(3)30-22)8-12-4-6-15-14(19(12)23)9-26-29-15/h4-7,9,11H,8,10H2,1-3H3,(H,26,29)(H,27,32)
InChIKeyLUYPQQJZYZMXPG-UHFFFAOYSA-N
XLogP3.78
TPSA97.72 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500474.90
LogP ≤ 53.78
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide?
The IUPAC name of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide (CID 159464097) is 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide.
What is the SMILES notation for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide?
The canonical SMILES for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide is CC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)c(F)c1F.
What is the InChIKey of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide?
The InChIKey is LUYPQQJZYZMXPG-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H21ClF2N6O2/c1-11(2)27-18(32)10-33-16-7-5-13(20(24)21(16)25)22-28-17(31(3)30-22)8-12-4-6-15-14(19(12)23)9-26-29-15/h4-7,9,11H,8,10H2,1-3H3,(H,26,29)(H,27,32).
What are the key properties of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide?
2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide has a molecular weight of 474.90 g/mol, XLogP of 3.78, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2,3-difluorophenoxy]-N-propan-2-ylacetamide is sourced from PubChem (CID 159464097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).